HALO logo
halo search icon
6160
BeOne Medicines Ltd.

6160 · BeOne Medicines Ltd.

167.00

HKD
1.80 (1.09%)
25/06/2026 12:00:00 AM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

HK$270.40B

PE

118.20

EV/EBITDA

53.1

DIV Yield

0%

Payout Ratio

0%

MQV Rating

1Very Strong

As at 25/06/2026 12:00:00 AM

Price Chart

Description

BeOne Medicines Ltd. is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. The firm portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Basel, Switzerland.

  • All-Companies
  • All-Consensus
  • Consensus Cheap
  • HALO 100
  • HALO 200
  • HALO 50
  • HALO All
  • HALO Balance Sheet
  • HALO Capital Efficiency
  • HALO Earnings Momentum
  • HALO GARP
  • HALO Growth
  • HALO Momentum

Key Fundamentals

EPS 3 yr Growth

-113.50%

EBITDA Margin

11.00%

Operating Cashflow

$8,791m

Free Cash Flow Return

23.10%

ROIC

5.90%

Interest Coverage

10.10

Quick Ratio

3.10

Performance

52 weeks range

Low 144.1 - 229.4

Trade Value (12mth)

US$27,377,631.00

1 week

6.1%

1 month

-7.53%

YTD

-9.49%

1 year

8.02%

All time high

278.60

Additional Data

Shares Outstanding (Fully Diluted)

1,505m

HALO Sector

Healthcare

Next Company Report Date

31-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

HKD

Short Sell (% of issue)

0.00

Consensus

Lock Icon

Unlock full consensus

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Very Strong

Garp

Very Strong

Mqv Small

Neutral

Momentum

Price

Strong

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

Valuation

Lock Icon

Unlock full dataset

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

No announcements available.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial
Want to learn more?Frequently asked questions.
1
What is the current share price of BeOne Medicines Ltd. (6160:HKG)?
Halo FAQ
The current share price of BeOne Medicines Ltd. (6160:HKG) is HKDHK$167.00.
2
What is the 52-week high share price for BeOne Medicines Ltd. (6160:HKG)?
Halo FAQ
The 52-week high share price for BeOne Medicines Ltd. (6160:HKG) is HKDHK$229.40.
3
What is the 52-week low share price for BeOne Medicines Ltd. (6160:HKG)?
Halo FAQ
The 52-week low share price for BeOne Medicines Ltd. (6160:HKG) is HKDHK$144.10.
4
What is the dividend yield for BeOne Medicines Ltd. (6160:HKG)?
Halo FAQ
BeOne Medicines Ltd. (6160:HKG) does not pay a dividend.
5
What was BeOne Medicines Ltd. (6160:HKG) last dividend payment?
Halo FAQ
BeOne Medicines Ltd. (6160:HKG) does not pay a dividend.
6
What is the franking level for BeOne Medicines Ltd. (6160:HKG)?
Halo FAQ
BeOne Medicines Ltd. (6160:HKG) has a franking level of 0.00%.
7
In which sector is BeOne Medicines Ltd. (6160:HKG) classified?
Halo FAQ
BeOne Medicines Ltd. (6160:HKG) is classified in the Healthcare.
8
What is the price-to-earnings (P/E) ratio for BeOne Medicines Ltd. (6160:HKG)?
Halo FAQ
The current P/E ratio for BeOne Medicines Ltd. (6160:HKG) is 118.20.